These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19398206)

  • 1. Mechanism of action of N-phenyl-N'-(2-chloroethyl)ureas in the colchicine-binding site at the interface between alpha- and beta-tubulin.
    Fortin S; Wei L; Moreau E; Labrie P; Petitclerc E; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2009 May; 17(10):3690-7. PubMed ID: 19398206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative molecular field and comparative molecular similarity indices analyses (CoMFA and CoMSIA) of N-phenyl-N'-(2-chloroethyl)ureas targeting the colchicine-binding site as anticancer agents.
    Fortin S; Labrie P; Moreau E; Wei L; Kotra LP; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(4):1914-26. PubMed ID: 18023585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
    Fortin S; Bouchon B; Chambon C; Lacroix J; Moreau E; Chezal JM; Degoul F; C-Gaudreault R
    J Pharmacol Exp Ther; 2011 Feb; 336(2):460-7. PubMed ID: 20978170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site.
    Fortin JS; Lacroix J; Desjardins M; Patenaude A; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2007 Jul; 15(13):4456-69. PubMed ID: 17498960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Phenyl-N'-(2-chloroethyl)ureas (CEUs) as potential antineoplastic agents. Part 3: role of carbonyl groups in the covalent binding to the colchicine-binding site.
    Moreau E; Fortin S; Lacroix J; Patenaude A; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2008 Feb; 16(3):1206-17. PubMed ID: 17998163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Phenyl-N'-(2-chloroethyl)ureas (CEU) as potential antineoplastic agents. Part 2: role of omega-hydroxyl group in the covalent binding to beta-tubulin.
    Fortin S; Moreau E; Patenaude A; Desjardins M; Lacroix J; Rousseau JL; C-Gaudreault R
    Bioorg Med Chem; 2007 Feb; 15(3):1430-8. PubMed ID: 17118664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antiproliferative activity evaluation and structure-activity relationships of novel aromatic urea and amide analogues of N-phenyl-N'-(2-chloroethyl)ureas.
    Fortin S; Moreau E; Lacroix J; Côté MF; Petitclerc E; C-Gaudreault R
    Eur J Med Chem; 2010 Jul; 45(7):2928-37. PubMed ID: 20400211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule disruption induced in vivo by alkylation of beta-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents.
    Legault J; Gaulin JF; Mounetou E; Bolduc S; Lacroix J; Poyet P; Gaudreault RC
    Cancer Res; 2000 Feb; 60(4):985-92. PubMed ID: 10706114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
    Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT; Barakat K; Tuszynski JA
    Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
    Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
    Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective alkylation of beta(II)-tubulin and thioredoxin-1 by structurally related subsets of aryl chloroethylureas leading to either anti-microtubules or redox modulating agents.
    Fortin JS; Côté MF; Lacroix J; Desjardins M; Petitclerc E; C-Gaudreault R
    Bioorg Med Chem; 2008 Aug; 16(15):7277-90. PubMed ID: 18617414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -NH-dansyl isocolchicine exhibits a significantly improved tubulin-binding affinity and microtubule inhibition in comparison to isocolchicine by binding tubulin through its A and B rings.
    Das L; Datta AB; Gupta S; Poddar A; Sengupta S; Janik ME; Bhattacharyya B
    Biochemistry; 2005 Mar; 44(9):3249-58. PubMed ID: 15736935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter.
    Bouchon B; Chambon C; Mounetou E; Papon J; Miot-Noirault E; Gaudreault RC; Madelmont JC; Degoul F
    Mol Pharmacol; 2005 Nov; 68(5):1415-22. PubMed ID: 16099845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramolecular cyclization of N-phenyl N'(2-chloroethyl)ureas leads to active N-phenyl-4,5-dihydrooxazol-2-amines alkylating β-tubulin Glu198 and prohibitin Asp40.
    Trzeciakiewicz A; Fortin S; Moreau E; C-Gaudreault R; Lacroix J; Chambon C; Communal Y; Chezal JM; Miot-Noirault E; Bouchon B; Degoul F
    Biochem Pharmacol; 2011 May; 81(9):1116-23. PubMed ID: 21371445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design and biological testing of highly cytotoxic colchicine ring A modifications.
    Torin Huzil J; Winter P; Johnson L; Weis AL; Bakos T; Banerjee A; Luduena RF; Damaraju S; Tuszynski JA
    Chem Biol Drug Des; 2010 Jun; 75(6):541-50. PubMed ID: 20408852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.
    Ravelli RB; Gigant B; Curmi PA; Jourdain I; Lachkar S; Sobel A; Knossow M
    Nature; 2004 Mar; 428(6979):198-202. PubMed ID: 15014504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
    Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
    J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.